Omeros Corporation (OMER)
NASDAQ: OMER · Real-Time Price · USD
9.79
-0.46 (-4.54%)
Jun 5, 2026, 3:57 PM EDT - Market open
Omeros Employees
Omeros had 175 employees as of December 31, 2025. The number of employees decreased by 27 or -13.37% compared to the previous year.
Employees
175
Change (1Y)
-27
Growth (1Y)
-13.37%
Revenue / Employee
$56,531
Profits / Employee
$492,400
Market Cap
708.19M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 175 | -27 | -13.37% |
| Dec 31, 2024 | 202 | 4 | 2.02% |
| Dec 31, 2023 | 198 | 2 | 1.02% |
| Dec 31, 2022 | 196 | -17 | -7.98% |
| Dec 31, 2021 | 213 | -64 | -23.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Phathom Pharmaceuticals | 371 |
| Kura Oncology | 260 |
| Geron | 258 |
| Allogene Therapeutics | 152 |
| Solid Biosciences | 121 |
| Aura Biosciences | 113 |
| Vor Biopharma | 76 |
| Oculis Holding AG | 60 |
OMER News
- 22 days ago - Omeros Earnings Call Transcript: Q1 2026 - Transcripts
- 22 days ago - Omeros Earnings release: Q1 2026 - Filings
- 22 days ago - Omeros Quarterly report: Q1 2026 - Filings
- 22 days ago - Omeros reports Q1 adjusted EPS (24c), consensus (28c) - TheFly
- 22 days ago - Omeros Corporation Reports First Quarter 2026 Financial Results - Business Wire
- 24 days ago - Omeros Corporation to Announce First Quarter Financial Results on May 13, 2026 - Business Wire
- 4 weeks ago - Kyverna Therapeutics appoints Nadia Dac as chief commercial officer - TheFly
- 5 weeks ago - Omeros Proxy statement: Proxy filing - Filings